-
公开(公告)号:US20240277900A1
公开(公告)日:2024-08-22
申请号:US18646092
申请日:2024-04-25
发明人: Arnav CHHABRA , Amanda CHEN , Keval N. VYAS , Thomas Jay LOWERY, JR. , Fabiola MUNARIN , Glenn Michael LA MURAGLIA, II , Timothy Alfred NORMAN, JR. , Christopher Garrison WILSON , Joseph E. MARTURANO , Morgan JAMIEL , Alison HAYWARD , Howard TAKIFF
CPC分类号: A61L27/3839 , A61F2/022 , A61L27/225 , A61L27/3813 , A61L27/44 , A61L27/52 , A61L27/54 , A61L2300/412 , A61L2430/28
摘要: The present disclosure provides engineered tissue constructs having hepatocytes and stromal cells and methods of making and using the same (e.g., for treating acute liver failure, a urea cycle disorder, or hyperbilirubinemia (e.g., in a subject having Crigler-Najjar syndrome) in a human subject in need thereof). The engineered tissue constructs may provide a microenvironment that promotes the persistence of hepatocyte survival for at least three months.
-
公开(公告)号:US20230132318A1
公开(公告)日:2023-04-27
申请号:US17827128
申请日:2022-05-27
发明人: Laura LANDE-DINER , Howard TAKIFF , Amanda CHEN , Arnav CHHABRA , Thomas Jay LOWERY, JR. , Morgan JAMIEL , Alison HAYWARD , Timothy Alfred NORMAN, JR. , Joseph E. MARTURANO
摘要: The present disclosure provides engineered tissue constructs having a population of cells, such as hepatocytes and stromal cells, and methods of making and using the same (e.g., for treating a disease or disorder, such as acute liver failure, a urea cycle disorder, or hyperbilirubinemia (e.g., in a subject having Crigler-Najjar syndrome) in a human subject in need thereof).
-